BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.48
-0.02 (-0.24%)
At close: Mar 6, 2026, 4:00 PM EST
8.60
+0.12 (1.42%)
After-hours: Mar 6, 2026, 7:37 PM EST
BioCryst Pharmaceuticals Employees
BioCryst Pharmaceuticals had 435 employees as of December 31, 2025. The number of employees decreased by 145 or -25.00% compared to the previous year.
Employees
435
Change (1Y)
-145
Growth (1Y)
-25.00%
Revenue / Employee
$2,011,120
Profits / Employee
$606,577
Market Cap
2.13B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,379 |
| Phibro Animal Health | 2,475 |
| HUTCHMED (China) | 1,780 |
| ANI Pharmaceuticals | 970 |
| Supernus Pharmaceuticals | 778 |
| Prestige Consumer Healthcare | 600 |
| Harrow | 373 |
BCRX News
- 3 days ago - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - BioCryst Pharmaceuticals, Inc. (BCRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - BioCryst Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 18 days ago - BioCryst to Present at Upcoming Investor Conference - GlobeNewsWire
- 24 days ago - BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting - GlobeNewsWire
- 4 weeks ago - BioCryst to Report Fourth Quarter 2025 Financial Results on February 26 - GlobeNewsWire
- 6 weeks ago - BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema - GlobeNewsWire
- 7 weeks ago - BioCryst Pharmaceuticals, Inc. (BCRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha